Literature DB >> 11908605

Determination of ABO blood grouping from human oral squamous epithelium by the highly sensitive immunohistochemical staining method EnVision+.

Hiroshi Noda1, Makoto Yokota, Shinji Tatsumi, Shizuyuki Sugiyama.   

Abstract

Using the highly sensitive immunohistochemical staining method EnVision+, which employs a dextran polymer reagent for the secondary antibody, the detection of the ABH antigens was attempted in the oral squamous epithelium. This new technique uses monoclonal antibody as a primary antibody and it takes about three hours for staining. The time is much shorter than conventional absorption-elution testing or absorption-inhibition testing for the determination of ABO blood grouping. Secretor saliva samples were stained at strong intensity by the antibody, which corresponded to its blood group and anti-H. On the one hand, nonsecretor saliva samples were stained at strong intensity only by the antibody that corresponded to its blood group, and at weak intensity only by anti-H. Since human oral squamous epithelium antigens were stained specifically by this method, we can examine the ABO blood group of saliva samples and perform cytodiagnosis at the same time. Our research suggested that the EnVision+ Method is a useful technique for ABO blood grouping of saliva in forensic cases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11908605

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  2 in total

1.  Binding patterns of human norovirus-like particles to buccal and intestinal tissues of gnotobiotic pigs in relation to A/H histo-blood group antigen expression.

Authors:  S Cheetham; M Souza; R McGregor; T Meulia; Q Wang; L J Saif
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

2.  Evaluation of the Secretor Status of ABO Blood Group Antigens in Saliva among Southern Rajasthan Population Using Absorption Inhibition Method.

Authors:  Rashmi Metgud; Nidhi Khajuria; Gayathri Ramesh
Journal:  J Clin Diagn Res       Date:  2016-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.